BCL2 and Miyoshi myopathy: Multiple studies have collectively indicated that VTC can extend the lifespan of MM patients by regulating apoptosis in MM cells through the modulation of the BCL-2 protein family (Fairbrother et al., 2019; Basu, 2022; Diepstraten et al., 2022).